Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate vs Cyclopol for painless gastrointestinal endoscopy
ChiCTR2200067192Phase 4Not yet recruiting
- Sponsor
- Ordos Central Hospital
- Start
- Jan 2023
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and ciprofol in None (2 arms), sponsored by Ordos Central Hospital. Primary endpoint: Operation completion success rate. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
remimazolamciprofol
Beyond the preview
Go deeper on ChiCTR2200067192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200067192.